Literature DB >> 36264505

Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours.

Yassine Bouchoucha1,2, Thomas Kergrohen3, Alice Métais4,5, Volodia Dangouloff-Ros6, Xavier Maynadier7, Yassine Ajlil3, Matthieu Carton7, Wael Yacoub6, Raphael Saffroy8, Dominique Figarella-Branger9, Emmanuelle Uro-Coste10, Annick Sevely11, Delphine Larrieu-Ciron12,13, Maxime Faisant14, Marie-Christine Machet15, Ellen Wahler16, Alexandre Roux17,18, Sandro Benichi19, Kevin Beccaria19, Thomas Blauwblomme19, Nathalie Boddaert6, Fabrice Chrétien16, François Doz1,2, Christelle Dufour20, Jacques Grill20, Marie Anne Debily3,21, Pascale Varlet16,17, Arnault Tauziède-Espariat16,17.   

Abstract

Pediatric spinal low-grade glioma (LGG) and glioneuronal tumours are rare, accounting for less 2.8-5.2% of pediatric LGG. New tumour types frequently found in spinal location such as diffuse leptomeningeal glioneuronal tumours (DLGNT) have been added to the World Health Organization (WHO) classification of tumours of the central nervous system since 2016, but their distinction from others gliomas and particularly from pilocytic astrocytoma (PA) are poorly defined. Most large studies on this subject were published before the era of the molecular diagnosis and did not address the differential diagnosis between PAs and DLGNTs in this peculiar location. Our study retrospectively examined a cohort of 28 children with LGGs and glioneuronal intramedullary tumours using detailed radiological, clinico-pathological and molecular analysis. 25% of spinal PAs were reclassified as DLGNTs. PA and DLGNT are nearly indistinguishable in histopathology or neuroradiology. 83% of spinal DLGNTs presented first without leptomeningeal contrast enhancement. Unsupervised t-distributed stochastic neighbor embedding (t-SNE) analysis of DNA methylation profiles showed that spinal PAs formed a unique methylation cluster distinct from reference midline and posterior fossa PAs, whereas spinal DLGNTs clustered with reference DLGNT cohort. FGFR1 alterations were found in 36% of spinal tumours and were restricted to PAs. Spinal PAs affected significantly younger patients (median age 2 years old) than DLGNTs (median age 8.2 years old). Progression-free survival was similar among the two groups. In this location, histopathology and radiology are of limited interest, but molecular data (methyloma, 1p and FGFR1 status) represent important tools differentiating these two mitogen-activated protein kinase (MAPK) altered tumour types, PA and DLGNT. Thus, these molecular alterations should systematically be explored in this type of tumour in a spinal location.
© 2022. The Author(s).

Entities:  

Keywords:  Diffuse leptomeningeal glioneuronal tumour; Glioneuronal tumour; Intramedullary glioma; Methylation profiling; Pediatric low-grade glioma; Pilocytic astrocytoma

Year:  2022        PMID: 36264505      PMCID: PMC9582396          DOI: 10.1007/s00401-022-02512-6

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   15.887


  46 in total

1.  STAR: ultrafast universal RNA-seq aligner.

Authors:  Alexander Dobin; Carrie A Davis; Felix Schlesinger; Jorg Drenkow; Chris Zaleski; Sonali Jha; Philippe Batut; Mark Chaisson; Thomas R Gingeras
Journal:  Bioinformatics       Date:  2012-10-25       Impact factor: 6.937

2.  FGFR1 N546K and H3F3A K27M mutations in a diffuse leptomeningeal tumour with glial and neuronal markers.

Authors:  Kyle Dyson; Marie Rivera-Zengotita; Jesse Kresak; Kristin Weaver; Brian Stover; John Fort; Maryam Rahman; David W Pincus; Elias J Sayour
Journal:  Histopathology       Date:  2016-07-04       Impact factor: 5.087

3.  Paediatric diffuse leptomeningeal tumor with glial and neuronal differentiation harbouring chromosome 1p/19q co-deletion and H3.3 K27M mutation: unusual molecular profile and its therapeutic implications.

Authors:  Aruna Nambirajan; Vaishali Suri; Sweta Kedia; Keshav Goyal; Prit Benny Malgulwar; Gaurav Khanna; Prateek Kumar Panda; Sheffali Gulati; Ajay Garg; Mehar Chand Sharma
Journal:  Brain Tumor Pathol       Date:  2018-07-20       Impact factor: 3.298

4.  Differential expression and methylation of brain developmental genes define location-specific subsets of pilocytic astrocytoma.

Authors:  Sally R Lambert; Hendrik Witt; Volker Hovestadt; Manuela Zucknick; Marcel Kool; Danita M Pearson; Andrey Korshunov; Marina Ryzhova; Koichi Ichimura; Nada Jabado; Adam M Fontebasso; Peter Lichter; Stefan M Pfister; V Peter Collins; David T W Jones
Journal:  Acta Neuropathol       Date:  2013-05-10       Impact factor: 17.088

5.  Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature.

Authors:  Aurélie Tchoghandjian; Carla Fernandez; Carole Colin; Ikbale El Ayachi; Brigitte Voutsinos-Porche; Frédéric Fina; Didier Scavarda; Marie-Dominique Piercecchi-Marti; Dominique Intagliata; L'Houcine Ouafik; Caroline Fraslon-Vanhulle; Dominique Figarella-Branger
Journal:  Brain       Date:  2009-03-31       Impact factor: 13.501

6.  A Diffuse Leptomeningeal Glioneuronal Tumor Without Diffuse Leptomeningeal Involvement: Detailed Molecular and Clinical Characterization.

Authors:  Jennifer H Kang; Anne F Buckley; Seema Nagpal; Nancy Fischbein; Katherine B Peters
Journal:  J Neuropathol Exp Neurol       Date:  2018-09-01       Impact factor: 3.685

7.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.

Authors:  Quinn T Ostrom; Nirav Patil; Gino Cioffi; Kristin Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2020-10-30       Impact factor: 12.300

8.  Molecular diagnostics helps to identify distinct subgroups of spinal astrocytomas.

Authors:  Annamaria Biczok; Felix L Strübing; Julia M Eder; Rupert Egensperger; Oliver Schnell; Stefan Zausinger; Julia E Neumann; Jochen Herms; Joerg-Christian Tonn; Mario M Dorostkar
Journal:  Acta Neuropathol Commun       Date:  2021-06-30       Impact factor: 7.801

9.  Molecular and clinicopathologic features of gliomas harboring NTRK fusions.

Authors:  Matthew Torre; Varshini Vasudevaraja; Jonathan Serrano; Michael DeLorenzo; Seth Malinowski; Anne-Florence Blandin; Melanie Pages; Azra H Ligon; Fei Dong; David M Meredith; MacLean P Nasrallah; Craig Horbinski; Sonika Dahiya; Keith L Ligon; Mariarita Santi; Shakti H Ramkissoon; Mariella G Filbin; Matija Snuderl; Sanda Alexandrescu
Journal:  Acta Neuropathol Commun       Date:  2020-07-14       Impact factor: 7.578

10.  The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population.

Authors:  Albane Gareton; Arnault Tauziède-Espariat; Volodia Dangouloff-Ros; Alexandre Roux; Raphaël Saffroy; David Castel; Thomas Kergrohen; Fréderic Fina; Dominique Figarella-Branger; Mélanie Pagès; Franck Bourdeaut; François Doz; Stéphanie Puget; Christelle Dufour; Emmanuèle Lechapt; Fabrice Chrétien; Jacques Grill; Pascale Varlet
Journal:  Acta Neuropathol       Date:  2019-11-01       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.